Literature DB >> 15737081

A sample size formula for the supremum log-rank statistic.

Kevin Hasegawa Eng1, Michael R Kosorok.   

Abstract

An advantage of the supremum log-rank over the standard log-rank statistic is an increased sensitivity to a wider variety of stochastic ordering alternatives. In this article, we develop a formula for sample size computation for studies utilizing the supremum log-rank statistic. The idea is to base power on the proportional hazards alternative, so that the supremum log rank will have the same power as the standard log rank in the setting where the standard log rank is optimal. This results in a slight increase in sample size over that required for the standard log rank. For example, a 5.733% increase occurs for a two-sided test having type I error 0.05 and power 0.80. This slight increase in sample size is offset by the significant gains in power the supremum log-rank test achieves for a wide range of nonproportional hazards alternatives. A small simulation study is used for illustration. These results should facilitate the wider use of the supremum log-rank statistic in clinical trials.

Mesh:

Year:  2005        PMID: 15737081     DOI: 10.1111/j.0006-341X.2005.031206.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

1.  Sample size formulae for two-stage randomized trials with survival outcomes.

Authors:  Zhiguo Li; Susan A Murphy
Journal:  Biometrika       Date:  2011-07-13       Impact factor: 2.445

2.  Partitioned log-rank tests for the overall homogeneity of hazard rate functions.

Authors:  Yukun Liu; Guosheng Yin
Journal:  Lifetime Data Anal       Date:  2016-03-19       Impact factor: 1.588

3.  Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks.

Authors:  Qing Yang; Wing K Fung; Gang Li
Journal:  Stat Med       Date:  2017-12-27       Impact factor: 2.497

4.  The use of restricted mean time lost under competing risks data.

Authors:  Jingjing Lyu; Yawen Hou; Zheng Chen
Journal:  BMC Med Res Methodol       Date:  2020-07-25       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.